Patents by Inventor Nathalie M. RIOUX

Nathalie M. RIOUX has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • A METHOD FOR TREATING CANCER WITH AN ORAL DOSAGE FORM OF AN FGFR4 INHIBITOR
    Publication number: 20230172867
    Abstract: The present invention relates to pharmaceutical compositions comprising an inhibitor of FGFR4, and methods of cancer therapy using the FGFR4 inhibitor. In particular, described herein are dosages of H3B-6527 with defined pharmacokinetic (PK) profiles that allow the inhibitor to be efficaciously and safely administered to a human subject in need thereof.
    Type: Application
    Filed: May 14, 2021
    Publication date: June 8, 2023
    Applicant: Eisai R&D Management Co., Ltd.
    Inventors: Jianjun XIAO, Nathalie M. Rioux
  • A METHOD FOR TREATING CANCER WITH AN ORAL DOSAGE FORM OF AN ESTROGEN RECEPTOR-ALPHA INHIBITOR
    Publication number: 20220226300
    Abstract: The present invention relates to pharmaceutical compositions comprising an inhibitor of human ER?, and methods of cancer therapy using the ER? inhibitor. In particular, described herein are dosages of H3B-6545 with defined pharmacokinetic (PK) profiles that allow the inhibitor to be efficaciously and safely administered to a human subject in need thereof.
    Type: Application
    Filed: May 15, 2020
    Publication date: July 21, 2022
    Applicant: Eisai R&D Management Co., Ltd.
    Inventors: Jianjun XIAO, Nathalie M. RIOUX, Victoria RIMKUNAS